This educational resource contains a range of content developed for healthcare professionals based in Europe who are involved in the treatment and management of type 2 diabetes mellitus. In this section you will find:
Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC) and should be able to:
Describe the psychosocial factors that can affect metabolic control
Discuss the rationale and clinical guideline recommendations for psychosocial screening in childhood diabetes
Explain the importance of family interactions and dynamics in diabetes management
Assess the different behavioural and psychological interventions for optimising diabetes management in children and adolescents
El Centro de Experiencia Jardiance▼® (Empagliflozina)*† proporciona información sobre el uso de Jardiance.
Jardiance está indicado como medicamento adicional en el tratamiento de la diabetes mellitus tipo 2 en pacientes adultos cuando en combinación con otros medicamentos hipoglucemiantes, junto con la dieta y el ejercicio, no proporcionen un control glucémico adecuado. También está indicado como monoterapia en pacientes adultos en los que el uso de metformina se considere inapropiado debido a una intolerancia.
Los usuarios encontraran cuatro videos de expertos analizando el uso de inhibidores de SGLT2 centrándose en:
El paciente adecuado
Posición recomendada en el escalón terapéutico
Mecanismo de acción
*Este contenido es de tipo promocional, esponsorizado por Boehringer Ingelheim y Lilly.
†▼Este medicamento está sujeto a seguimiento adicional, es prioritaria la notificación de sospechas de reacciones adversas a este medicamento
The Obesity Learning Hub contains clinical information and resources for healthcare professionals involved in the treatment and management of obese or overweight patients.
Here you will find a Knowledge Centre with information on epidemiology, pathophysiology, clinical guidelines, assessment and treatment options, prevention methods and more. Other sections within the Learning Hub include a clinical media library, news and journal articles, events information, patient guides and the EACCME-accredited European Obesity Initiative CME series, which is worth five European CME Credits (ECMECs) in total.
This EACCME-accredited obesity CME series contains three CME modules, which are ideal for healthcare professionals looking to improve their understanding of obesity as a serious medical illness.
Module 1 – Understanding Obesity
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy.
Module 3 – Rationale for Lifelong Behaviour Change
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy.
Diabetes care is a hot topic in medicine since it touches so many primary care settings; from maternity to foot care, Diabetes has multiple other pathologies. When does Diabetes care necessitate the role of a specialist? How can diabetologists ensure they work innovatively and make the patient's healthcare journey as seamless as possible? Dr. Partha Kar dives in, asking how healthcare professionals can make positive change to patients with Diabetes in Britain's NHS.
3 days ago -
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Background: Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapies. We assessed ...
This guideline updates and replaces the sections for children and young people in type 1 diabetes..
... (NICE guideline CG15).
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends strict targets for blood glucose control to reduce the long-term risks associated with diabetes.
Healthcare professionals can enhance their understanding of the combination therapies available for treating type 2 diabetes by completing this free activity. ‘Best Practice in Type 2 Diabetes: Update on Incretin...
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy....
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as human regular U-500 insulin (U-500R) administered by continuous subcutaneous insulin infusion (CSII) ...
Slides from ESOT 2015 are now available to view and download free of charge in the congresses section of the Anti-Infectives Knowledge
Network – Invasive Fungal Infections. Discussions focus on managing infection in solid organ transplantation.
November 2015 MYC/15/0052/EU